Aspire-Lakewood (ASBP) vs Lantern Pharma (LTRN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Aspire-Lakewood (ASBP) has outperformed Lantern Pharma (LTRN) over the past year, losing 43.0% versus a loss of 81.9%. Lantern Pharma is the larger company by market cap ($12.4 million vs $11.6 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ASBP | LTRN |
|---|---|---|
| Share price | $8.30 | $0.83 |
| Market cap | $11.64M | $12.40M |
| 1-day change | -3.82% | -8.79% |
| YTD return | +57.20% | -72.61% |
| 1-year return | -42.99% | -81.92% |
| 5-year return | — | -91.71% |
| EPS (TTM) | $-30.89 | $-1.50 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $18.76 | $4.68 |
| 52-week low | $0.11 | $0.83 |
| Distance from 52-week high | -55.76% | -82.26% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +2008.43% |
| Average volume | 36.92K | 180.42K |
| Shares outstanding | 1.40M | 14.94M |
| Employees | — | 16 |
| Sector | Consumer Cyclical | Healthcare |
| Industry | Auto Parts | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ASBP has outperformed LTRN by 38.9 percentage points over the past year.
- The two companies sit in different sectors: Aspire-Lakewood in Consumer Cyclical and Lantern Pharma in Healthcare.
About Aspire-Lakewood
ASBP stock →Aspire-Lakewood Holdings, Inc. develops sublingual drug delivery technology and manufactures automotive and industrial control systems.
Consumer Cyclical · Auto Parts
About Lantern Pharma
LTRN stock →Lantern Pharma Inc. focuses on the discovery and development of oncology drug in India.
Healthcare · Biotechnology · 16 employees
ASBP vs LTRN FAQ
Which is bigger, Aspire-Lakewood or Lantern Pharma?
Lantern Pharma (LTRN) is larger, with a market capitalization of $12.40M compared with $11.64M for Aspire-Lakewood (ASBP).
Which stock has performed better over the past year, ASBP or LTRN?
ASBP returned -42.99% over the past 12 months, compared with -81.92% for LTRN (price return, excluding dividends). Past performance does not predict future results.
Are Aspire-Lakewood and Lantern Pharma in the same industry?
No. Aspire-Lakewood is in the Consumer Cyclical sector, while Lantern Pharma is in Healthcare.